Nutrition and Prostate cancer;Nutrition et cancer de prostate

Progres en Urologie

Volumn 10, Issue 4, 2000, Pages 505-512

  Guy, Laurent ^a   Remesy, Christian ^b   Demigne, Christian ^b   Boiteux, Jean Paul ^a  

^a SERVICE DE RHUMATOLOGIE   (France)

^b CEMAGREF   (France)

Author keywords

Fats; Nutrition; Phytoestrogens; Prostate cancer

Indexed keywords

FLAVONOID; PHENOL DERIVATIVE; POLYMER; POLYPHENOLS; TRACE ELEMENT;

DIET; FAT INTAKE; HUMAN; MALE; PROSTATE TUMOR; REVIEW;

DIET; DIETARY FATS; FLAVONOIDS; HUMANS; MALE; MICRONUTRIENTS; PHENOLS; POLYMERS; PROSTATIC NEOPLASMS;

EID: 0034267868     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (101)

1. AGULLO G., GAMET-PAYRASTRE L., FERNANDEZ Y., ANCIAUX N., DEMIGNE C., REMESY C. : Comparative effects of flavonoids on the growth, viability and metabolism of a colonic adenocarcinoma cell line (HT29 cells). Cancer Lett., 1996, 105, 61-70.
2. AKIYAMA T., ISHIDA J., NAKAGAWA S., OGAWARA H., WATANABE S., ITOH N.M., SHIBUYA M., FUKAMI Y. : Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem., 1987, 262, 5592-5595.
3. ALDERCREUTZ H., MARKANNEN H., WATANABE S. : Plasma concentrations of phytoestrogens in Japanese men. Lancet, 1993, 13, 1209-1210.
4. ALPHA TOCOPHEROL, BETA CAROTENE CANCER PREVENTION STUDY GROUP : The effect of Vitamin E and beta carotene on the incidence of lung cancers and other cancers in male smokers. N. Engl. J. Med., 1994, 330, 1029-1035.
5. ANDERSSON S.O., WOLK A., BERGSTRÖM R., GIOVANNUCCI E., LINDGREN C., BARON J., ADAMI H.O. : Energy, nutrient intake and prostate cancer risk: a population-based case-control study in sweden. Int. J. Cancer, 1996, 68, 716-722.
6. ANTILA E., MUSSALO-RAUHAMAA H., KANTOLA M., ATROSHI F., WESTERMARCK T. : Association of cadmium with human breast cancer. Sci. Total Environ., 1996, 186, 251-256.
7. BAIRATI I., MEYER F., FRADET Y., MOORE L. : Dietary fat and advanced prostate cancer. J. Urol., 1998, 159, 1271-1275.
8. BARNES S. : Effect of genistein on in vitro and in vivo models of cancer. J. Nutr., 1995, 125, 777S-783S.
9. BERGER U., WILSON P., McCLELLAND R.A., COLSTON K., HAUSSLER M.R., PIKE J.W., COOMBES R.C. : Immunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues. J. Clin. Endocrinol. Metab., 1988, 67, 607-613.
10. BRESLOW N., CHAN C.W., DHOM G., DRURY R.A., FRANKS L.M., GELLEI B., LEE Y.S., LUNDBERG S., SPARKE B., STERNBY N.H., TULINIUS H. : Latent carcinoma of the prostate at autopsy in seven areas. Int. J. Cancer, 1977, 20, 680-688.
11. CAMPBELL M.J., ELSTNER E., HOLDEN S., USKOKOVIC M., KOEFFLER H.P. : Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin. J. Mol. Endocrinol., 1997,19, 15-27.
12. CAMPBELL M.J., PARK S., USKOKOVIC M.R., DAWSON M.I., JONG L., KOEFFLER H.P. : Synergistic inhibition of prostate cancer cell lines by a 19-nor hexafluoride vitamin D3 analogue and anti-activator protein 1 retinoid. Br. J. Cancer, 1999, 79, 101-107.
13. CHECKOWAY H., DIFERDINANDO G., HULKA B.S., MICKEY D.D. : Medical, life-style, and occupational risk factors for prostate cancer. Prostate, 1987, 10, 79-88.
14. CLARK L.C., COMBS G.F. Jr, TURNBULL B.W., SLATE E.H., CHALKER D.K., CHOW J., DAVIS L.S., GLOVER R.A., GRAHAM G.F., GROSS E.G., KRONGRAD A., LESHER J.L. Jr, PARK H.K., SANDERS B.B. Jr, SMITH C.L., TAYLOR J.R. : Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. J.A.M.A., 1996, 276, 1957-1963.
15. CLARK L.C., DALKIN B., KRONGRAD A., COMBS G.F. Jr, TURNBULL B.W., SLATE E.H., WITHERINGTON R., HERLONG J.H., JANOSKO E., CARPENTER D., BOROSSO C., FALK S., ROUNDER J. : Decreased incidence of prostate cancer with selenium supplementation :results of a double-blind cancer prevention trial. Br. J. Urol., 1998, 81, 730-734.
16. COMSTOCK G.W., BUSH T.L., HELZLSOUER K. : Serum retinol, beta-carotene, vitamin E, and selenium as related to subsequent cancer of specific sites. Am. J. Epidemiol., 1992, 135, 115-121.
17. CONNOLLY J.M., COLEMAN M., ROSE D.P. : Effects of dietary fatty acids on DU145 human prostate cancer cell growth in athymic nude mice. Nutr. Cancer, 1997, 29, 114-119.
18. DENEO-PELLEGRINI H., DE STEFANI E., RONCO A., MENDILAHARSU M. : Foods, nutrients and prostate cancer : a case-control study in Uruguay. Br. J. Cancer, 1999, 80, 591-597.
19. DIPAOLA R.S., ZHANG H., LAMBERT G.H., MEEKER R., LICITRA E., RAFI M.M., ZHU B.T., SPAULDING H., GOODIN S., TOLEDANO M.B., HAIT W.N., GALLO M.A. : Clinical and biological activity of an estrogenic herbal combinaison (PC-SPES) in prostate cancer. N. Engl. J. Med., 1998, 339, 785-791.
20. ELGHANY N.A., SCHUMACHER M.C., SLATTERY M.L., WEST D.W., LEE J.S. : Occupation, cadmium exposure, and prostate cancer. Epidemiology, 1990, 1, 107-115.
21. ELINDER C.G., KJELLSTROM T., HOGSTEDT C., ANDERSSON K., SPANG G. : Cancer mortality of cadmium workers. Br. J . Ind. Med., 1985, 42, 651-655.
22. FINCHAM S.M., HILL G.B., HANSON J., WIJAYASINGHE C. : Epidemiology of prostatic cancer: a case control study. Prostate, 1990, 17, 189-206.
23. FLESHNER N., FAIR W.R., HURYK R., HESTON W.D.W. : Vitamin E inhibits the high-fat diet promoted growth of established human prostate LNCaP tumors in nude mice. J. Urol., 1999, 161, 1651-1654.
24. FOTSIS T., PEPPER M., ALDERKREUTZ H., HASE T., MONTESANO R., SCHWEIGERER L. : Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J. Nutr. 1995, 125, 790S-797S.
25. GERSTER H. : The potential role of lycopene for human health. J. Amer. Coll. Nutr. 1997, 16, 109-126.
26. GIOVANNUCCI E. : Dietary influence of 1,25(OH)2 vitamin D in relation to prostate cancer: a hypothesis. Cancer Causes Control, 1998, 9, 567-582.
27. GIOVANNUCCI E. : Selenium and risk of prostate cancer. Lancet, 1998, 352, 755-756.
28. GIOVANNUCCI E., ASCHERIO A., RIMM E.B., STAMPFER M.J., COLDITZ G.A., WILLETT W.C. : Intake of carotenoids and retinol in relation to risk of prostate cancer. J. Natl. Cancer Inst., 1995, 87 , 1767-1776.
29. GIOVANNUCCI E., RIMM E.B., COLDITZ G.A., STAMPER M.J., ASCHERIO A., CHUTE C.C., WILLETT W.C. : A prospective study of dietary fat and risk of prostate cancer. J. Natl. Cancer Inst., 1993, 85, 1571-1579.
30. GIOVANNUCCI E., RIMM E.B., WOLK A., ASCHERIO A., STAMPFER M.J., COLDITZ G.A., WILLETT W.C. : Calcium and fructose intake in relation to risk of prostate cancer. Cancer Res., 1998, 58, 442-447.
31. GRAHAM S., HAUGHEY B., MARSHALL J., PRIORE R., BYERS T., RZEPKA T., METTLIN C., PONTES J.E. : Diet in the epidemiology of carcinoma of the prostate gland. J. Natl. Cancer Inst., 1983, 70, 687-692.
32. GROSS C., STAMEY T., HANCOCK S., FELDMAN D. : Treatment of early recurrent prostate cancer zith 1-25-dihydroxyvitamin D3 (calcitriol). J. Urol., 1998, 159, 2035-2040.
33. HAYES R.B., ZIEGLER R.G., GRIDLEY G., SWANSON C., GREENBERG R.S., SWANSSON G.M., SCHOENBERG J.B., SILVERMAN D.T., BROWN L.M., POTTERN L.M., LIFF J., SCHWARTZ A.G., FRAUMENI J.F. JR, HOOVER R.N. : Dietary factors and risks for prostate cancer among blacks and whites in the United States. Cancer Epidemiol. Biomarkers Prev., 1999, 8, 25-34.
34. HEMPSTOCK J., KAVANAGH J.P., GEORGE N.J.R. : Growth inhibition of prostate cell lines in vitro by phyto-oestrogens. Br. J. Urol., 1998, 82, 560-563.
35. HESHMAT M.Y., KAUL L., JACKSON M.A., JACKSON A.G., JONES G.W., EDSON M., ENTERLINE J.P., WORRELL R.G., PERRY S.L. : Nutrition and prostate cancer : a case-control study. Prostate, 1985, 6, 7-17.
36. HOFFMANN L., PUTZKE H.P., KAMPEHL H.J., RUSSBULT R., GASE P., SIMONN C., ERDMANN T., HUCKSTORF C. : Carcinogenic effects of cadmium on the prostate of the rat. J. Cancer Res. Clin. Oncol., 1985, 109, 193-199.
37. HSING A.W., COMSTOCK G.W., ABBEY H., POLK B.F. : Serologic precursors of cancer. Retinol, carotenoids, and tocopherol and risk of prostate cancer. J. Natl Cancer Inst., 1990, 82, 941-946.
38. HSING A.W., MCLAUGHLIN J.K., SCHUMAN L.M., BJELKE E., GRIDLEY G., WACHOLDER S., CHIEN H.T., BLOT W.J. : Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study. Cancer Res., 1990, 50, 6836-6840.
39. IARC HANDBOOKS OF CANCER PREVENTION, volume 2 : carotenoids, 1998.
40. JACOBSEN B.K., KNUTSEN S.F., FRASER G.E. : Does high soy milk intake reduce prostate cancer incidence ? Cancer Causes Control, 1998, 9, 553-557.
41. KAUL L., HESHMAT M.Y., KOVI J., JACKSON M.A., JACKSON A.G., JONES G.W., EDSON M., ENTERLINE J.P., WORRELL R.G., PERRY S.L. : The role of diet in prostate cancer. Nutr. Cancer, 1987, 9, 123-128.
42. KEY T.J.A., SILCOCKS P.B., DAVEY G.K., APPLEBY P.N., BISHOP D.T. : A case-control study of diet and prostate cancer. Br. J. Cancer, 1997, 76, 678-687.
43. KOLONEL L.N. : Association of cadmium with renal cancer. Cancer, 1976, 37, 1782-1787.
44. KOLONEL L.N., YOSHIZAWA C.N., HANKIN J.H. : Diet and prostate cancer : a case control study in Hawaii. Am. J. Epidemiol., 1988, 127, 999-1012.
45. KRILL D., STONER J. , KONETY B.R., BECICH M.J., GETZENBERG R.H. : Differential effects of vitamin D on normal human prostate epithelial and stromal cells in primary culture. Urology, 1999, 54, 171-177.
46. LANDSTROM M., ZHANG J.X., HALLMANS G., AMAN P., BERGH A., DAMBER J.E., MAZUR W., WAHALA K., ADLERCREUTZ H. : Inhibitory effects of soy and rye diets on the development of Dunning R3327 prostate adenocarcinoma in rats. Prostate, 1998, 36, 151-161.
47. LE MARCHAND L., HANKIN J.H., KOLONEL L.N., WILKENS L.R. : Vegetables and fruit consumption in relation to prostate cancer risk in Hawaii : a reevaluation of effects of dietary beta-carotene. Am. J. Epidemiol., 1991, 133, 215-219.
48. LEE M.M., WANG R.T., HSING A.W., GU F.L., WANG T., SPITZ M. : Case-control study of diet and prostate cancer in China. Cancer Causes Control, 1998, 9, 545-552.
49. LIANG T., LIAO S. : Inhibition of steroid 5 alpha-reductase by specific aliphatic unsaturated fatty acids. Biochem J., 1992, 285, 557-562.
50. LUCIA M.S., ANZANO M.A., SLAYTER M.V., ANVER M.R., GREEN D.M., SHRADER M.W., LOGSDON D.L., DRIVER C.L., BROWN C.C., PEER C.W., et al : Chemopreventive activity of tamoxifen, N-(4-hydroxyphenyl)retinamide, and the vitamin D analogue Ro24-5531 for androgen-promoted carcinomas of the rat seminal vesicle and prostate. Cancer Res., 1995, 55, 5621-5627.
51. MAKELA S., PYLKKANEN L., SANTTI R ., ADLERCREUTZ H. : Role of plant estrogen in normal and estrogen-altered growth of the mouse prostate. In: Institute of Technology, Effects of food on the Immune and Hormonal Systems, University of Zurich and Swiss Federal Institute of Technology, Schwerzenbach, Switzerland, 1991, pp. 135-139.
52. MARKOVITZ J., LINASSIER C., FOSSE P., COUPRIE J., PIERRE J., JACQUEMIN-SABLON A., SAUCIER J.M., LE PECQ J.B., LARSON A.K. : Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res., 1989, 49, 5111-5117.
53. METTLIN C., SELENSKAS S., NATARAJAN N., HUBEN R. : Beta-carotene and animal fats and their relationship to prostate cancer risk: a case control study. Cancer, 1989, 64, 605-612.
54. MILLER G.J., STAPLETON G.E., FERRARA J.A., LUCIA M.S., PFISTER S., HEDLUNG T.E., UPADHYA P. : The human prostatic cell line LNCaP expresses biologically active, specific receptors for 1a,25-dihydroxyvitamin D3. Cancer Res., 1992, 52, 515-520.
55. MILLER G.J., STAPLETON G.E., HEDLUNG T.E., MOFFAT K.A. : Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines. Clin. Cancer Res., 1995, 1, 997-1003.
56. MILLS P.K., BEESON W.L., PHILIPS R.L., FRASER G.E. : Cohort study of diet, lifestyle and prostate cancer in adventist men. Cancer, 1989, 64, 598-604.
57. MISHINA T., WATANABE H., ARAKI H., NAKAO M. : Epidemiological study of prostatic cancer by matched -pair analysis. Prostate, 1985, 6, 423-436.
58. MORTON M.S., MATOS-FERREIRA A., ABRANCHES-MONTEIRO L., CORREIRA R., BLACKLOCK N., CHAN P.S.F., CHENG C., Lloyd S., CHIEHPING W., GRIFFITHS K. : Measurement and metabolism of isoflavonoids and lignans in human male. Cancer Lett., 1997, 114, 145-151.
59. MOYAD M.A., PIENTA K.J., MONTIE J.E. : Use of PC-SPES, a commercially available supplement for prostate cancer, in a patient with hormone-naive disease. Urology, 1999, 54, 319-323.
60. MUIR C.S., NECTOUX J., STASZEWSKI J. : The epidemiology of prostatic cancer : geographical distribution and time-trends. Acta Oncol., 1991, 30, 133-140.
61. NAIK H.R., LEHR J.E., PIENTA K.J. : An in vitro and in vivo study of antitumor effects of genistein on hormone refractory prostate cancer. Anticancer Research, 1994, 14, 2617-2620.
62. OHNO Y., YOSHIDA O., OISHI K., OKADA K., YAMABE H., SCHROEDER F.H. : Dietary beta-carotene and cancer of the prostate: a case control study in Kyoto , Japan. Cancer res., 1988, 48, 1131-1136.
63. OSBORN J.L., SCHWARTZ G.G., SMITH D.C., BAHNSON R., DAY R., TRUMP D.L. : Phase II trial of oral 1,25-dihydroxyvitamin D (calcitriol) in hormone refractory prostate cancer. Urol. Oncol., 1995, 1, 195.
64. PARKER S.L., TONG T., BOLDEN S., WINGO P.A. : Cancer statistics, 1996. CA Cancer J. Clin., 1996, 46, 5-27.
65. PARKIN D.M., MUIR C.S. : Cancer incidence in in five continents: comparability and quality of data. I.A.R.C. Sci. Publ., 1992, 120, 45-173.
66. PETERSON G. : Evaluation of the biochemical targets of genisteinin tumor cells. J. Nutr., 1995, 125, 784S-789S.
67. PETERSON G., BARNES S. : Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor autophosphorylation. Prostate, 1993, 22, 335-345.
68. RAO A.V., FLESHNER N., AGARWAL S. : Serum and tissue lycopene and biomarkers of oxidation in prostate cancer patients. Nutr. Cancer, 1999, 33, 159-164.
69. ROONEY C., BERAL V., MACONOCHIE N., FRASER P., DAVIES G. : Case-control study of prostatic cancer in employees of the United Kingdom Atomic Energy Authority. B.M.J., 1993, 307, 1391-1397.
70. ROSE D.P., COHEN L.A. : Effects of dietary menhaden oil and retinyl acetate on the growth of DU-145 human prostatic adenocarcinoma cells transplanted into athymic nude mice. Carcinogenesis, 1988, 9, 603-605.
71. ROSE D.P., CONNOLLY J.M. : Effects of fatty acids and eicosanoid synthesis inhibitors on the growth of two human prostate cancer cell lines. Prostate, 1991, 54, 520-525.
72. ROSS R.K., SHIMIZU H., PAGANANINI-HILL A., HONDA G., HENDERSON B.E. Case control studies of prostate cancer in blacks and whites in Southern California. J. Natl. Cancer Inst., 1987, 78, 869-874.
73. ROTKIN I.D. : Studies in the epidemiology of prostatic cancer : expanded sampling. Cancer Treat. Rev., 1977, 61, 173-180.
74. SAKR W.A., HAAS G.P., CASSIN B.F., PONTES J.E., CRISSMAN J.D. : The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol, 1993, 150, 379-385.
75. SCHWARTZ G.G., HILL C.C., OELER T.A., BECICH M.J., BAHNSON R.R. : 1,25-Dihydroxy-16-ene-23-yne-vitamin D3 and prostate cancer cell proliferation in vivo. Urology, 1995, 46, 365-369.
76. SCHWARTZ G.G., HULKA B.S. : Is vitamin D deficiency a risk factor for prostate cancer ? (Hypothesis). Anticancer Res., 1990, 10, 1307-1310.
77. SCHWARTZ G.G., WANG M.H., ZANG M.H., SINGH R.K., SIEGAL G.P. : 1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells. Cancer Epidemiol. Biomarkers Prev., 1997, 6, 727-732.
78. SEVERSON R.K., NOMURA A.M., GROVE J.S., STEMMERMANN G.N. : A prospective study of demographics, diet, and prostate cancer among men of japanese ancestry in Hawaii. Cancer Res., 1989, 49, 1857-1860.
79. SHAMBERGER R.J., FROST D.V. : Possible protective effect of selenium against human cancer. Can. Med. Assoc. J., 1969, 100, 682.
80. SHARMA O.P., ADLERCREUTZ H., STRANDBERG J.D., ZIRKIN B.R., COFFEY D.S. : Soy of dietary source plays a preventive role against the pathogenesis of prostatitis in rats. J. Steroid Biochem. Mol. Biol., 1992, 43, 557-564.
81. SHIMIZU H., ROSS R.K., BERNSTEIN L., YATANI R., HENDERSON B.E., MACK T.M. : Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br. J. Cancer, 1991, 63, 963-966.
82. SKOWRONSKI R.J., PEEHL D.M., FELDMAN D. : Vitamin D and prostate cancer : 1,25-Dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines. Endocrinology, 1993, 132, 1952-1960.
83. SMITH D.C., JOHNSON C.S., FREEMAN C.C., MUINDI J., WILSON J.Z., TRUMP D.L. : A phase I trial of calcitriol (1.25-dihydroxycholecalciferol) in patients with advanced malignancy. Clin. Cancer Res., 1999, 5, 1339-1345.
84. SNOWDON D.A., PHILIPS R.L., CHOI W. : Diet, obesity and risk of fatal prostate cancer. Am. J. epidemiol., 1984, 120, 244-250.
85. STAYNER L., SMITH R., THUN M., SCHNORR T., LEMEN R. : A dose-response analysis and quantitative assessment of lung cancer risk and occupational cadmium exposure. Ann. Epidemiol., 1992, 2, 177-194.
86. TALAMINI R., LA VECCHIA C., DECARLI A., NEGRI E., FRANCESCHI S. : Nutrition , social factors and prostatic cancer in a Northern Italian population. Br. J. Cancer, 1986, 53, 817-821.
87. TIWARI R.K., GELIEBTER J., GARIKAPATY V.P., YEDAVELLI S.P., CHEN S., MITTELMAN A. : Anti-tumor effects of PC-SPES, an herbal formulation in prostate cancer. Int. J. Oncol., 1999, 14, 713-719.
88. TZONOU A., SIGNORELLO L.B., LAGIOU P., WUU J., TRICHOPOULOS D., TRICHOPOULOU A. : Diet and cancer of the prostate : a case control study in Greece. Int. J. Cancer, 1999, 80, 704-708.
89. VAN DEN GULDEN J.W., KOLK J.J, VERBEEK A.L. : Work environment and prostate cancer risk. Prostate, 1995, 27, 250-257.
90. VEIEROD M.B., LAAKE P., THELLE D.S. : Dietary fat intake and risk of prostate cancer: a prospective study of 25708 norvegian men. Int. J. Cancer, 1997, 73, 634-638.
91. WAALKES M.P., REHM S., RIGGS C.W., BARE R.M., DEVOR D.E., POIRIER L.A., WENK M.L., HENNEMAN J.R., BALASCHAK M.S. : Cadmium carcinogenesis in male Wistar [Crl :(WI)BR] rats : dose-response analysis of tumor induction in the prostate and testes and at the injection site. Cancer Res., 1988, 48, 4656-4663.
92. WALKER A.R., WALKER B.F., TSOTETSI N.G., SEBITSO C., SIWEDI D., WALKER A.J. : Case-control study of prostate cancer in black patients in Soweto, South Africa. Br. J. Cancer, 1992, 65, 438-441.
93. WANG X., CHEN X., AKHTER J., MORRIS D.L. : The in vitro effect of vitamin D3 analogue EB-1089 on a human prostate cancer cell line (PC-3). Br. J. Urol., 1997, 80, 260-262.
94. WANG Y., CORR J.G., THALER H.T., TAO Y., FAIR W.R., HESTON W.D. : Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J. Natl. Cancer Inst., 1995, 87, 1456-1462.
95. WANG Y., HESTON D.W., FAIR W.R. : Soy isoflavones decrease the high-fat promoted growth of human prostate cancer - Results of in vitro and animal studies. J Urol, 1995, 153, 269A. Abstract 161.
96. WEST D.W., SLATTERY M.L., ROBINSON L.M., FRENCH T.K., MAHONEY A.W. : Adult dietary intake and prostate cancer risk in Utah: a case control study with special emphasis on aggressive tumors. Cancer Causes Control. 1991, 2, 85-94.
97. WHITTEMORE A.S., KOLONEL L.N., WU A.H., JOHN E.M., GALLAGHER R.P., HOWE G.R., BURCH J.D., HANKIN J., DREON D.M., WEST D.W. : Prostate cancer in relation to diet, physical activity and body size in blacks, whites and Asians in the United states and Canada. J. Natl. Cancer Inst., 1995, 87, 652-661.
98. WILLETT W.C., POLK B.F., UNDERWOOD B.A., STAMPFER M.J., PRESSEL S., ROSNER B., TAYLOR J.O., SCHNEIDER K., HAMES C.G. : Relation of serum vitamins A and E and carotenoids to the risk of cancer. N. Engl. J. Med., 1984, 310, 430-434.
99. XUE L., LIPKIN M., NEWMARK H. : Influence of dietary calcium and vitamin D on diet-induced epithelial cell hyperproliferation in mice. J. Natl. Cancer Inst., 1999, 20, 176-181.
100. ZHANG J.X., HALLMANS G., LANDSTROM M., BERGH A., DAMBER J.-E., AMAN P., ALDERCREUTZ H. : Soy and rye diets inhibit the development of Dunning R3327 prostatic adenocarcinoma in rats. Cancer Lett., 1997, 114, 313-314.
101. ZHOU J.-R., GUGGER E.T., TANAKA T., GUO Y., BLACKBURN L ., CLINTON S.K. : Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice. J. Nutr., 1999, 129, 1628-1635.